Taysha Gene Therapies Stock (TSHA)
Track Taysha Gene Therapies stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
TSHA
Taysha Gene Therapies
healthcare
$5.93
▲ +3.15 (+121.15%) past year
Market Cap
$1.58B
P/E Ratio
—
1Y Return
+121.15%
EPS (TTM)
-$0.40
Read the latest TheStreet Pro articles mentioning Taysha Gene Therapies, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning TSHA yet.
Daily Diary Mentions
0 mentionsNo diary mentions for TSHA yet.